Cognitive function in people with psychiatric and neurological disorders in UK Biobank

Cullen, Breda (2018) Cognitive function in people with psychiatric and neurological disorders in UK Biobank. PhD thesis, University of Glasgow.

Full text available as:
[img]
Preview
PDF
Download (12MB) | Preview

Abstract

Cognitive impairment is a major cause of disability for a large number of working-age adults living with chronic psychiatric and neurological conditions. Although well recognised in schizophrenia spectrum disorders and in neurological diseases such as multiple sclerosis (MS), cognitive impairment has historically received less attention in mood disorders. The relative prevalence of cognitive impairment in bipolar disorder (BD) and major depression compared with other conditions has not been clearly established, and the risk factors that drive cognitive variation within and across conditions are not well understood.
The primary focus of this thesis was on BD, and the objectives were: (1) to investigate the prevalence of cognitive impairment in BD, compared with major depression, schizophrenia, MS and Parkinson’s disease (PD); and (2) to develop causal models to quantify and explain variation in cognitive function in BD and in other conditions. The methods encompassed a systematic literature review, a prevalence study using cross-sectional data from the UK Biobank cohort, and a series of multivariable analyses of UK Biobank data using graphical methods, regression- and matching-based estimation, and mediation models.
The systematic review indicated that between 5% and 58% of adults with euthymic BD showed cognitive impairment. Prevalence was lower in the mania/BD group identified within the UK Biobank cohort, at around 7-10%, which was similar to rates seen in the MS and PD groups within the cohort. When causal models of cognitive performance in the mania/BD group took account of multiple potential confounders, performance on a short-term visuospatial memory test showed a small but reliable decrement. Mediation models provided evidence of indirect negative effects on cognitive performance via psychotropic medication, but not via cardiometabolic disease. A similar pattern of results was seen in the major depression group, though with smaller effect sizes.
This thesis emphasises the importance of cognitive function as a fundamental phenotype in psychiatric and epidemiological research. There is scope to build on this work in future follow-up waves in UK Biobank, as well as in other UK and international cohort studies and through linkage with routine healthcare data.

Item Type: Thesis (PhD)
Qualification Level: Doctoral
Keywords: Mood disorders, cognitive impairment, UK Biobank.
Subjects: B Philosophy. Psychology. Religion > BF Psychology
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Colleges/Schools: College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Mental Health and Wellbeing
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Public Health
Funder's Name: Scottish Executive Health Department
Supervisor's Name: Evans, Professor Jonathan and Pell, Professor Jill and Smith, Professor Daniel
Date of Award: 2018
Depositing User: Dr Breda Cullen
Unique ID: glathesis:2018-30769
Copyright: Copyright of this thesis is held by the author.
Date Deposited: 11 Sep 2018 15:32
Last Modified: 19 Oct 2018 07:01
URI: http://theses.gla.ac.uk/id/eprint/30769
Related URLs:

Actions (login required)

View Item View Item